Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Abstract Although the clinical development of immune checkpoint inhibitors (ICIs) therapy has ushered in a new era of anti-tumor therapy, with sustained responses and significant survival advantages observed in multiple tumors, most patients do not benefit. Therefore, more and more attention has bee...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Rilan Bai, Zheng Lv, Dongsheng Xu, Jiuwei Cui
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2020-08-01
Edice:	Biomarker Research
Témata:	Neoplasm Immune checkpoint inhibitor Predictive biomarker Tumor mutation burden Programmed death ligand-1
On-line přístup:	http://link.springer.com/article/10.1186/s40364-020-00209-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!